课题基金 / 基金详情

Analysis for acetylation status of microtubules in epithelial mesenchymal transition induced by HGF/MET stimulation

Analysis for acetylation status of microtubules in epithelial mesenchymal transition induced by HGF/MET stimulation
HGF/MET刺激诱导的上皮间质转化中微管乙酰化状态分析
批准号:
23590431
负责人:
MASUDA Tomoyuki
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

MASUDA Tomoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在探讨HDAC6在肝细胞癌(HCC)侵袭转移活动中的意义。我们还研究了HGF/MET系统对上皮间质转化的影响。与原代培养的肝细胞相比,HDAC6在所有HCC细胞系中的表达都更高。敲低HDAC6可显著下调所有HCC细胞系的迁移和侵袭活性(P<0.05)。70例原发性hcc中有14例(20%)HDAC6蛋白过表达高于相应的正常肝细胞,且与临床分期高、肿瘤数量多、血管侵犯及肝内转移相关(P<0.05)。HDAC6的下调抑制ERK1/2向核素的转运。这些结果表明HDAC6蛋白的过表达参与了HCC细胞的EMT。
英文摘要
The aim of this study was to investigate the significance of HDAC6 in the invasion and metastasis activities of hepatocellular carcinoma (HCC). And we also examined the effect on epithelial mesenchymal trsnsition induced by HGF/MET system. HDAC6 expression was greater in all of the HCC cell lines compared to the primary cultures of hepatocytes. Knockdown of HDAC6 markedly downregulated the migration and invasion activities of all HCC cell lines (P<0.05). Overexpression of HDAC6 protein to a level higher than that in the corresponding normal hepatocytes was observed in 14 (20%) of the 70 primary HCCs, and was significantly correlated with high clinical stage, number of tumors, vascular invasion and intrahepatic metastasis (P<0.05). Downregulation of HDAC6 inhibited ERK1/2 tranlocation to the nuclesu. These results suggest that overexpression of the HDAC6 protein is involved in EMT of HCC cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2013
期刊: J Clin Exp Hematop
影响因子: 1.5
作者: [Sakurai E, Satoh T, Akiko YA, Maesawa C, Tsunoda K, Endo M, Akasaka T, Masuda T.]
通讯作者: Masuda T.
DOI: 10.3892/ijo.2012.1424
发表时间: 2012-07-01
期刊: INTERNATIONAL JOURNAL OF ONCOLOGY
影响因子: 5.2
作者: [Ishikawa, Yuichi, Tsunoda, Kanako, Maesawa, Chihaya]
通讯作者: Maesawa, Chihaya
Sensor and effector kinases in DNAdamage checkpoint regulate capacity for homologous recombination repair offission yeast in G2 phase.
DNA 损伤检查点中的传感器和效应激酶调节 G2 期同源重组修复裂殖酵母的能力。
DOI: 10.1016/j.dnarep.2012.05.006
发表时间: 2012
期刊: DNA Repair (Amst).
影响因子: --
作者: [Yasuhira S, Saito T, Maesawa C, Masuda T.]
通讯作者: Masuda T.
Sternoclavicular joint septic arthritis following paraspinal muscle abscess and septic lumbar spondylodiscitis with epidural abscess in a patient with diabetes: a case report.
糖尿病患者椎旁肌脓肿后胸锁关节化脓性关节炎和合并硬膜外脓肿的化脓性腰椎间盘炎:病例报告。
DOI: --
发表时间: 2012
期刊: BMC Emerg Med
影响因子: 2.5
作者: [Shioya N, Ishibe Y, Kan S, Masuda T, Matsumoto N, Takahashi G, Makabe H, Yamada Y, Endo S.]
通讯作者: Endo S.
Analysis of Mutual Influence Relationships Based on a Comparison of Byzantine and Medieval Italian Church Decoration Programs
  • 批准号:
    18H00632
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $7.49万
  • 财政年份:
    2018
  • 负责人:
    MASUDA Tomoyuki
  • 依托单位:
Historical Study of the Cultural Diversity in the Central Balkan Peninsula
  • 批准号:
    22320030
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $4.66万
  • 财政年份:
    2010
  • 负责人:
    MASUDA Tomoyuki
  • 依托单位:
A Historical Study on the Publication of Copybooks in the Qing Dynasty of China
  • 批准号:
    22720266
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    MASUDA Tomoyuki
  • 依托单位:
Analyses of novel genes expressed in the embryonic spinal cord with reference to the sensory axonal guidance
  • 批准号:
    21590218
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2009
  • 负责人:
    MASUDA Tomoyuki
  • 依托单位:
国内基金
海外基金
靶向抑制HDAC6介导STAT1乙酰化修饰调控cDC2-CD4+T细胞互作缓解肠道炎症的机制研究
  • 批准号:
    2026JJ81338
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    艾飞艳
  • 依托单位:
鼻咽癌rs11130424通过HDAC6/CACNA2D3调控放免协同的分子机制研究
  • 批准号:
    2026JJ81656
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谢小雪
  • 依托单位:
黄芪多糖调控HDAC6 O-GlcNAcylation影响Piezo1介导的铁死亡参与激素性股骨头坏死的机制研究
靶向并降解雄激素受体的AR/HDAC6双靶点抑制剂的设计、筛选及其在耐药前列腺癌中的活性研究
  • 批准号:
    2026JJ50636
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周茂军
  • 依托单位: